A few methodologic issues of note

Schizophrenia Bulletin

Volumn 34, Issue 6, 2008, Pages 1003-1005

  Carpenter, William T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HALOPERIDOL; NEUROLEPTIC AGENT;

AKINESIA; ANHEDONIA; ANXIETY DISORDER; BEHAVIOR; BIPOLAR DISORDER; COGNITION; DELUSIONAL DISORDER; DEPRESSION; DYSPHORIA; EDITORIAL; EMOTIONAL DISORDER; GENOTYPE PHENOTYPE CORRELATION; HUMAN; LEARNING DISORDER; MAJOR DEPRESSION; MENTAL DISEASE; MENTAL HEALTH; MENTAL PERFORMANCE; MOOD DISORDER; NEGATIVE SYNDROME; PARANOIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SIDE EFFECT; SOCIAL INTERACTION; TEMPORAL LOBE EPILEPSY;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENOTYPE; HUMANS; PERCEPTUAL DISTORTION; PHENOTYPE; REALITY TESTING; RESEARCH DESIGN; SCHIZOPHRENIA; VOLITION;

EID: 54249147347     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbn125     Document Type: Editorial

References (20)

1. Kraepelin E. Dementia Praecox and Paraphrenia. In: Barclay RM, trans. Huntington, NY: Robert E. Kreiger; 1893/1971.
2. Kirkpatrick B, Fenton WS, Carpenter WT, Jr, Marder SR. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull. 2006;32:214-219.
3. Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull. 2006;32:238-245.
4. Carpenter WT, Buchanan RW, Kirkpatrick B, Thaker G, Tamminga CT. Negative symptoms: a critique of current approaches. In: Marneros A, Andreasen NC, Tsuang MT, eds. Negative Vs. Positive Schizophrenia. Proceedings of the Workshop on Negative/Positive Schizophrenia, June 29-30, 1990, Bonn, Germany. Heidelberg, Germany: Springer-Verlag; 1991:126-133.
5. Carpenter WT, Strauss JS, Bartko JJ. Beyond diagnosis: the phenomenology of schizophrenia. Am J Psychiatry. 1981;138: 948-953.
6. Carpenter WT, Heinrichs DW, Alphs LD. Treatment of negative symptoms. Schizophr Bull. 1985;11:440-452.
7. Carpenter WT, Heinrichs DW, Wagman AMI. Deficit and non-deficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583.
8. Carpenter WT. Psychopathology and common sense: where we went wrong with negative symptoms. [editorial]. Biol Psychiatry. 1991;29:735-737.
9. Carpenter WT. The negative symptom challenge. Arch Gen Psychiatry. 1992;49:236-237.
10. Carpenter WT. The deficit syndrome [editorial]. Am J Psychiatry. 1994;151:327-329.
11. Carpenter WT. Syndromes of schizophrenia [editorial]. Br J Psychiatry. 1994;165:721-727.
12. Kirkpatrick B, Carpenter WT. Drug development & the deficit syndrome of schizophrenia [editorial]. Biol Psychiatry. 1995;38:277-278.
13. Carpenter WT. Understanding the concepts of negative symptoms. J Clin Psychiatry. 1997;15:12-16.
14. Kirkpatrick B, Kopelowicz A, Buchanan RW, Carpenter WT. Assessing the efficacy of treatments for the deficit syndrome of schizophrenia. Neuropsychopharmacology. 2000;22: 303-310.
15. Carpenter WT, Gold JM. Another view of therapy for cognition in schizophrenia. [editorial]. Biol Psychiatry. 2002;52: 969-971.
16. Buchanan RW, Davis M, Goff D, et al. A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia. Schizophr Bull. 2005;31:5-19.
17. Carpenter WT, Buchanan RW, Kirkpatrick B, Tamminga CA, Wood F. Strong inference, theory falsification,and the neuroanatomy of schizophrenia. Arch Gen Psychiatry. 1993;50:825-831.
18. Carpenter WT, Arango C, Buchanan RW, Kirkpatrick B. Deficit psychopathology and a paradigm shift in schizophrenia research. Biol Psychiatry. 1999;46:352-360.
19. Braff DL. Introduction: the use of endophenotypes to deconstruct and understand the genetic architecture, neurobiology, and guide future treatments of the group of schizophrenias. Schizophr Bull. 2007;33:19-20.
20. Thaker G. Psychosis endophenotypes in schizophrenia and bipolar disorder. Schizophr Bull. 2008;34:720-721.